Annual CFF
$5.97 M
-$2.65 M-30.79%
December 1, 2023
Summary
- As of February 8, 2025, KPRX annual cash flow from financing activities is $5.97 million, with the most recent change of -$2.65 million (-30.79%) on December 1, 2023.
- During the last 3 years, KPRX annual CFF has risen by +$968.60 thousand (+19.38%).
- KPRX annual CFF is now -66.07% below its all-time high of $17.58 million, reached on December 31, 2021.
Performance
KPRX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$0.00
-$250.50 K-100.00%
September 1, 2024
Summary
- As of February 8, 2025, KPRX quarterly cash flow from financing activities is $0.00, with the most recent change of -$250.50 thousand (-100.00%) on September 1, 2024.
- Over the past year, KPRX quarterly CFF has stayed the same.
- KPRX quarterly CFF is now -100.00% below its all-time high of $15.25 million, reached on March 1, 2024.
Performance
KPRX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$15.01 M
$0.000.00%
September 1, 2024
Summary
- As of February 8, 2025, KPRX TTM cash flow from financing activities is $15.01 million, unchanged on September 1, 2024.
- Over the past year, KPRX TTM CFF has increased by +$5.32 million (+54.83%).
- KPRX TTM CFF is now -27.48% below its all-time high of $20.70 million, reached on March 1, 2024.
Performance
KPRX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
KPRX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -30.8% | 0.0% | +54.8% |
| 3 y3 years | +19.4% | -100.0% | -0.4% |
| 5 y5 years | -47.2% | -100.0% | -0.4% |
KPRX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -66.1% | at low | -100.0% | +100.0% | -27.5% | +190.6% |
| 5 y | 5-year | -66.1% | +52.2% | -100.0% | +100.0% | -27.5% | +282.9% |
| alltime | all time | -66.1% | +8012.6% | -100.0% | +100.0% | -27.5% | >+9999.0% |
Kiora Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(-100.0%) | $15.01 M(0.0%) |
| Jun 2024 | - | $250.50 K(-98.4%) | $15.01 M(-27.5%) |
| Mar 2024 | - | $15.25 M(-3234.8%) | $20.70 M(+247.0%) |
| Dec 2023 | $5.97 M(-30.8%) | -$486.40 K(<-9900.0%) | $5.97 M(-38.5%) |
| Sep 2023 | - | $0.00(-100.0%) | $9.70 M(-35.7%) |
| Jun 2023 | - | $5.94 M(+1057.3%) | $15.07 M(+65.0%) |
| Mar 2023 | - | $513.20 K(-84.2%) | $9.13 M(+6.0%) |
| Dec 2022 | $8.62 M(-51.0%) | $3.24 M(-39.7%) | $8.62 M(+66.9%) |
| Sep 2022 | - | $5.38 M(>+9900.0%) | $5.17 M(-45.9%) |
| Jun 2022 | - | $0.00(0.0%) | $9.54 M(0.0%) |
| Mar 2022 | - | $0.00(-100.0%) | $9.54 M(-45.7%) |
| Dec 2021 | $17.58 M(+251.8%) | -$212.30 K(-102.2%) | $17.58 M(-2.4%) |
| Sep 2021 | - | $9.76 M(>+9900.0%) | $18.01 M(+118.2%) |
| Jun 2021 | - | $0.00(-100.0%) | $8.26 M(-3.3%) |
| Mar 2021 | - | $8.04 M(+3587.6%) | $8.54 M(+70.8%) |
| Dec 2020 | $5.00 M(+27.5%) | $218.00 K(>+9900.0%) | $5.00 M(-42.5%) |
| Sep 2020 | - | $0.00(-100.0%) | $8.69 M(+0.2%) |
| Jun 2020 | - | $278.20 K(-93.8%) | $8.67 M(+2.9%) |
| Mar 2020 | - | $4.50 M(+15.2%) | $8.42 M(+114.8%) |
| Dec 2019 | $3.92 M(-65.3%) | $3.91 M(<-9900.0%) | $3.92 M(+3085.0%) |
| Sep 2019 | - | -$15.80 K(-152.0%) | $123.10 K(-74.2%) |
| Jun 2019 | - | $30.40 K(-2000.0%) | $476.90 K(-95.8%) |
| Mar 2019 | - | -$1600.00(-101.5%) | $11.35 M(+0.4%) |
| Dec 2018 | $11.30 M | $110.10 K(-67.4%) | $11.30 M(+0.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $338.00 K(-96.9%) | $11.25 M(+3.1%) |
| Jun 2018 | - | $10.90 M(<-9900.0%) | $10.90 M(+23.8%) |
| Mar 2018 | - | -$43.60 K(-185.7%) | $8.81 M(-17.5%) |
| Dec 2017 | $10.67 M(+205.1%) | $50.90 K(-1690.6%) | $10.67 M(+0.5%) |
| Sep 2017 | - | -$3200.00(-100.0%) | $10.62 M(-0.0%) |
| Jun 2017 | - | $8.80 M(+382.9%) | $10.62 M(+99.6%) |
| Mar 2017 | - | $1.82 M(<-9900.0%) | $5.32 M(+52.1%) |
| Dec 2016 | $3.50 M(-72.3%) | -$2900.00(+2800.0%) | $3.50 M(-0.3%) |
| Sep 2016 | - | -$100.00(-100.0%) | $3.51 M(-71.5%) |
| Jun 2016 | - | $3.50 M(>+9900.0%) | $12.33 M(+40.8%) |
| Mar 2016 | - | $0.00(-100.0%) | $8.76 M(-30.6%) |
| Dec 2015 | $12.62 M(+1957.1%) | $8300.00(-99.9%) | $12.62 M(-2.4%) |
| Sep 2015 | - | $8.82 M(<-9900.0%) | $12.93 M(+222.5%) |
| Jun 2015 | - | -$68.50 K(-101.8%) | $4.01 M(-0.4%) |
| Mar 2015 | - | $3.86 M(+1088.6%) | $4.02 M(+556.1%) |
| Dec 2014 | $613.30 K(-58.0%) | $324.50 K(-414.4%) | $613.30 K(+109.3%) |
| Sep 2014 | - | -$103.20 K(+90.4%) | $293.00 K(-78.5%) |
| Jun 2014 | - | -$54.20 K(-112.1%) | $1.36 M(-3.8%) |
| Mar 2014 | - | $446.20 K(>+9900.0%) | $1.42 M(-3.1%) |
| Dec 2013 | $1.46 M(-2037.7%) | $4200.00(-99.6%) | $1.46 M(+0.3%) |
| Sep 2013 | - | $964.70 K(>+9900.0%) | $1.46 M(+196.0%) |
| Jun 2013 | - | $0.00(-100.0%) | $492.10 K(0.0%) |
| Mar 2013 | - | $492.10 K | $492.10 K |
| Dec 2012 | -$75.40 K | - | - |
FAQ
- What is Kiora Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Kiora Pharmaceuticals?
- What is Kiora Pharmaceuticals annual CFF year-on-year change?
- What is Kiora Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Kiora Pharmaceuticals?
- What is Kiora Pharmaceuticals quarterly CFF year-on-year change?
- What is Kiora Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Kiora Pharmaceuticals?
- What is Kiora Pharmaceuticals TTM CFF year-on-year change?
What is Kiora Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of KPRX is $5.97 M
What is the all time high annual CFF for Kiora Pharmaceuticals?
Kiora Pharmaceuticals all-time high annual cash flow from financing activities is $17.58 M
What is Kiora Pharmaceuticals annual CFF year-on-year change?
Over the past year, KPRX annual cash flow from financing activities has changed by -$2.65 M (-30.79%)
What is Kiora Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of KPRX is $0.00
What is the all time high quarterly CFF for Kiora Pharmaceuticals?
Kiora Pharmaceuticals all-time high quarterly cash flow from financing activities is $15.25 M
What is Kiora Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, KPRX quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Kiora Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of KPRX is $15.01 M
What is the all time high TTM CFF for Kiora Pharmaceuticals?
Kiora Pharmaceuticals all-time high TTM cash flow from financing activities is $20.70 M
What is Kiora Pharmaceuticals TTM CFF year-on-year change?
Over the past year, KPRX TTM cash flow from financing activities has changed by +$5.32 M (+54.83%)